Conformation-X Therapeutics, LLC

About Conformation-X Therapeutics, LLC

Conformation X is pioneering a new class of drugs that activate the immune system to recognize cancer cells as foreign invaders, helping patients mount a natural anti-tumor response. Their therapeutics target the tumor microenvironment, recruiting and amplifying the patient's immune system to fight cancer. They aim to develop breakthrough therapies for hard-to-treat cancers and increase treatment success rates.

Products & Services

First-in-class biologics: Innovative biologic drugs targeting immune checkpoints in cancer treatment.

Orally available small molecule drugs: Small molecule drugs designed to target immune checkpoints with novel mechanisms of action.

HHLA2 and IL18BP programs: Lead assets with successful ex vivo and in vivo proof-of-concept studies for cancer drug development.

Specialties

Immune system activation for cancer treatment Tumor microenvironment targeting Development of first-in-class biologics Small molecule drug innovation Immune checkpoint targeting

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Undisclosed T: - FT: Undisclosed	A: 3650000 MR: - FA: $3.65M FAN: 3650000	D: 2024-04-03 FD: 2024-04-03	-

Undisclosed Latest

2024-04-03

$3.6M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News